Vakaramoko Diaby to Receptors, Estrogen
This is a "connection" page, showing publications Vakaramoko Diaby has written about Receptors, Estrogen.
Connection Strength
0.112
-
Diaby V, Adunlin G, Ali AA, Tawk R. Using quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trial. Breast Cancer Res Treat. 2014 Aug; 146(3):669-73.
Score: 0.112